Targeted Killing of Breast Cancer Cells by p95HER2-T Cell Bispecific Antibody
Immunotherapy was positioned as an emerging and even promising treatment for cancer. Today’s new immunotherapeutic agents for different tumor types, whether used alone or in combination, are increasingly becoming one of theRead More…